More Globe Newswire

View Older Stories View Newer Stories

Feb 17, 2026 07:05AM FLSmidth announces intention to initiate a new share buy-back programme of up to DKK 1.0 billion
Feb 17, 2026 07:05AM Lifecore Biomedical to Participate at DCAT Week 2026
Feb 17, 2026 07:05AM Kraig Biocraft Laboratories Activates First Wave of 2026 Production Program
Feb 17, 2026 07:05AM Crane NXT Announces Live Webcast of 2026 Investor Day
Feb 17, 2026 07:04AM OroraTech Appoints Distributed Satellite Pioneer Ignacio Zuleta as CTPO to Lead the Next Era of Global Thermal Intelligence
Feb 17, 2026 07:02AM Applitools Strengthens Leadership Team to Drive Next Phase of Growth
Feb 17, 2026 07:01AM Gilat Receives $9 Million Order for Defense SATCOM Solutions from Israel’s Ministry of Defense
Feb 17, 2026 07:00AM DCIP Geophysical Survey Underway on VR’s Bonita Porphyry Copper-Gold Project in Nevada
Feb 17, 2026 07:00AM Wallbridge Launches 2026 Exploration and Technical Studies Programs
Feb 17, 2026 07:00AM Ocular Therapeutix™ Reports Positive Results from Landmark SOL-1 Phase 3 Superiority Trial in Wet AMD
Feb 17, 2026 07:00AM NexLiving Communities Announces Property Disposition and Declares Quarterly Dividend
Feb 17, 2026 07:00AM Westhaven Launches 50,000m 2026 Drill Program at the Shovelnose Gold and Silver Project, Southern British Columbia
Feb 17, 2026 07:00AM Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack™ Kits
Feb 17, 2026 07:00AM BioCryst to Present at Upcoming Investor Conference
Feb 17, 2026 07:01AM Bridging Continents and Capital: How ADIS26 Connects Africa’s Innovators with Silicon Valley
Feb 17, 2026 07:01AM Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Feb 17, 2026 07:00AM Krystal Biotech Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
Feb 17, 2026 07:00AM Yorkshire Publishing Earns BBB® Accreditation
Feb 17, 2026 07:00AM Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
Feb 17, 2026 07:00AM EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Feb 17, 2026 07:00AM eToro Reports Fourth Quarter and Full Year 2025 Results
Feb 17, 2026 07:00AM Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study
Feb 17, 2026 07:00AM Can-Fite Announces Scientific Breakthrough Publication Demonstrating Anti-Obesity Effect of Namodenoson
Feb 17, 2026 07:00AM AtaiBeckley To Participate in Upcoming Investor Conferences
Feb 17, 2026 07:00AM Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica
Feb 17, 2026 07:00AM NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting
Feb 17, 2026 07:00AM Brunswick Exploration Lauches Phase 2 Drilling at Anatacau Lithium Discovery
Feb 17, 2026 07:00AM Zefiro Founder and Former Chairman Provides Details of Entrenchment Tactics to be Subject to Upcoming BCSC Hearing
Feb 17, 2026 07:00AM Amplify ETFs Files Two Fixed Income Covered Call ETFs
Feb 17, 2026 07:00AM Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Alkem Laboratories Ltd.
Feb 17, 2026 07:00AM Lucidworks Launches AI Ranking Insights to Improve e-Commerce Merchandiser Experiences
Feb 17, 2026 07:00AM Arvinas to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Feb 17, 2026 07:00AM Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
Feb 17, 2026 07:00AM OTC Markets Group Welcomes Headwater Gold Inc. to OTCQX
Feb 17, 2026 07:00AM OTC Markets Group Welcomes Goliath Resources Ltd. to OTCQX
Feb 17, 2026 07:00AM Perspective Therapeutics to Provide Business Highlights and Report Full Year 2025 Financial Results
Feb 17, 2026 07:00AM Total Economic Impact™ Study Finds Organizations Achieved 176% ROI With Dayforce
Feb 17, 2026 07:00AM Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
Feb 17, 2026 07:00AM OTC Markets Group Welcomes Ballston Spa Bancorp, Inc. to OTCQX
Feb 17, 2026 07:00AM Essential Pharma strengthens rare disease portfolio with acquisition of Ventavis® (iloprost trometamol) for adult primary pulmonary hypertension
Feb 17, 2026 06:55AM YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
Feb 17, 2026 06:55AM YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
Feb 17, 2026 06:50AM Skeena Gold & Silver Releases Construction Video Update for Eskay Creek
Feb 17, 2026 06:50AM Skeena Gold & Silver Releases Construction Video Update for Eskay Creek
Feb 17, 2026 06:45AM Castellum, Inc. Pays Off All Debt
Feb 17, 2026 06:45AM Vesta Freight Drives 18x Shipment Growth with Descartes’ Transportation Management Solution Suite
Feb 17, 2026 06:45AM Brown & Brown, Inc. acquires the assets of The Protectorate Group Insurance Agency, Inc., doing business as American Adventure Insurance
Feb 17, 2026 06:45AM Brown & Brown, Inc. acquires the assets of The Protectorate Group Insurance Agency, Inc., doing business as American Adventure Insurance
Feb 17, 2026 06:30AM Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026
Feb 17, 2026 06:30AM InterDigital renews license agreement with Sony
View Newer Stories View Older Stories